Class II · Moderate risk
Losartan Potassium Tablets
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Class II drug recalls - moderate risk
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,543 recalls, newest first.
Class II · Moderate risk
Losartan Potassium Tablets
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Class II · Moderate risk
Thyro-H
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
BioMycin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Worm Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Voice Rescue
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Vitiligo Off Ointment
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Vigo-XXX
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Vertigo Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Tution 130
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Thyro-Lo
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Sweat Oil
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Sugar Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Stomach Cleanser
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Sperm Booster
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Skin Moist
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Skin Lift Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Skin Lift
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Skin De-Tag
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Skin Cleanser
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Reman-AP
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Reman-8
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Reman-6
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Purple Gold Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Purple Gold Balm
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs